Japan's Pharmaceutical and Medical Device Agency Finds BioCardua's CardiAMP Cell Therapy Sufficient To Support Market Clearance

Benzinga Newsdesk www.benzinga.com Positive 94.9%

Neg 0% Neu 0% Pos 94.9%

Comments

No comments yet. Be the first!